Evidence map›Paper›PMID 25295583›Full record

ArticleArchives of pathology & laboratory medicine2015

Proteomic analysis of oral cavity squamous cell carcinoma specimens identifies patient outcome-associated proteins.

Thomas M Harris, Peicheng Du, Nicole Kawachi, Thomas J Belbin, Yanhua Wang, Nicolas F Schlecht, Thomas J Ow, Christian E Keller, Geoffrey J Childs, Richard V Smith and 3 more

Abstract read
In one paragraph

Article in Archives of pathology & laboratory medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Molecular Mechanisms Leading from Periodontal Disease to Cancer.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Thomas M HarrisFrom the Departments of Pathology (Drs Harris, Belbin, Wang, Ow, Childs, Prystowsky, and Lim and Ms Kawachi), Epidemiology & Population Health (Dr Schlecht), Developmental and Molecular Biology (Dr Angeletti), and Biochemistry (Dr Angeletti) and the Laboratory for Macromolecular Analysis & Proteomics (Drs Angeletti and Lim), Albert Einstein College of Medicine, Bronx, New York; High Performance and Research Computing, Department of Information Systems and Technology, UMDNJ, Newark, New Jersey (Dr Du); the Department of Otorhinolaryngology-Head & Neck Surgery, Montefiore Medical Center, Bronx, New York (Drs Ow and Smith); and the Department of Pathology, Henry Ford Hospital and Medical Group, Detroit, Michigan (Dr Keller).
Peicheng Du
Nicole Kawachi
Thomas J Belbin
Yanhua Wang
Nicolas F Schlecht
Thomas J Ow
Christian E Keller
Geoffrey J Childs
Richard V Smith
Ruth Hogue Angeletti
Michael B Prystowsky
Jihyeon Lim
Montefiore Medical Center · USAlbert Einstein College of Medicine · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025750 · NCRR · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SHAMOON, HARRY · 2008 to 2011
$20.5M
Proteomic analysis of head & neck squamous cell cancerR33CA103547 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI PRYSTOWSKY, MICHAEL B · 2008 to 2009
$1.9M
Clinical and Translational Science Award-K12KL2RR025749 · NCRR · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SHAMOON, HARRY · 2008 to 2011
$991k
Imaging Mass Spectrometry SystemS10RR025128 · NCRR · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI ANGELETTI, RUTH HOGUE · 2011 to 2011
$586k
MASS SPECTROMETER SYSTEMS10RR015859 · NCRR · YESHIVA UNIVERSITY · PI ANGELETTI, RUTH HOGUE · 2001 to 2001
$485k
Clinical and Translational Science Award-T32 (TL1)TL1RR025748 · NCRR · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SHAMOON, HARRY · 2008 to 2011
$385k
Proteomic analysis of head &neck squamous cell cancerR21CA103547 · NCI · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI PRYSTOWSKY, MICHAEL B · 2004 to 2005
$296k
2D-DIGE SYSTEM FOR PROTEOMICS: SIGNAL TRANSDUCT &CELL COMMUNICAT, &CELL BIOLS10RR021056 · NCRR · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI ANGELETTI, RUTH HOGUE · 2005 to 2005
$180k
NCATS NIH HHS UL1 TR001073NCI NIH HHS P30 CA013330NCI NIH HHS P30CA013330NCI NIH HHS R21 CA103547NCI NIH HHS R21CA103547NCI NIH HHS R33 CA103547NCI NIH HHS R33CA103547NCRR NIH HHS KL2 RR025749NCRR NIH HHS KL2RR025749NCRR NIH HHS S10 RR015859NCRR NIH HHS S10RR015859NCRR NIH HHS S10 RR021056NCRR NIH HHS S10RR021056NCRR NIH HHS S10 RR025128NCRR NIH HHS S10RR025128NCRR NIH HHS TL1 RR025748NCRR NIH HHS TL1RR025748NCRR NIH HHS UL1 RR025750NCRR NIH HHS UL1RR025750
6 · The paper itself

Abstract

contextGlobal proteomic analysis of oral cavity squamous cell carcinoma was performed to identify changes that reflect patient outcomes.

objectivesTo identify differentially expressed proteins associated with patient outcomes and to explore the use of imaging mass spectrometry as a clinical tool to identify clinically relevant proteins.

designTwo-dimensional separation of digested peptides generated from 43 specimens with high-resolution mass spectrometry identified proteins associated with disease-specific death, distant metastasis, and loco-regional recurrence. RNA expressions had been correlated to protein levels to test transcriptional regulation of clinically relevant proteins. Imaging mass spectrometry explored an alternative platform for assessing clinically relevant proteins that would complement surgical pathologic diagnosis.

resultsSeventy-two peptide features were found to be associated with 3 patient outcomes: disease-specific death (9), distant metastasis (16), and loco-regional recurrence (39); 8 of them were associated with multiple outcomes. Functional ontology revealed major changes in cell adhesion and calcium binding. Thirteen RNAs showed strong correlation with their encoded proteins, implying transcriptional control. Reduction of DSP, PKP1, and TRIM29 was associated with significantly shorter time to onset of distant metastasis. Reduction of PKP1 and TRIM29 correlated with poorer disease-specific survival. Additionally, S100A8 and S100A9 reductions were verified for their association with poor prognosis using imaging mass spectrometry, a platform more adaptable for use with surgical pathology.

conclusionsUsing global proteomic analysis, we have identified proteins associated with clinical outcomes. The list of clinically relevant proteins observed will provide a means to develop clinical assays for prognosis and optimizing treatment selection.

Indexed as

AgedCarcinoma, Squamous CellChromatography, LiquidDisease-Free SurvivalFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateMaleMiddle AgedMouth NeoplasmsPeptidesPrognosisProteomeProteomicsSequence Analysis, ProteinPeptidesProteome

Identifiers

PMID25295583
PMCPMC4380852
OpenAlexW1999187348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.